Acasti Pharma reported CAD54.54M in Current Assets for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Current Assets Change
Acasti Pharma ACST:US C$ 54.54M 7.83M
Addus Homecare ADUS:US $ 299.71M 9.3M
Agile Therapeutics AGRX:US 21.76M 15.19M
Amarin AMRN:US $ 963.03M 32.95M
Bioscrip BIOS:US $ 811.18M 75.42M
Genetic Technologies GENE:US $ 22.24M 4.15M
Pain Therapeutics PTIE:US $ 251.92M 27.64M